ADEKA Pharmaceuticals

What ADEKA Pharmaceuticals does

ADEKA Pharmaceuticals (legal name: Adeka İlaç Sanayi A.Ş., DBA: Adeka) is a Turkish pharmaceutical manufacturer founded in 1956 and headquartered at Eskibüyükdere Caddesi Numara 35, Maslak, Istanbul. The company is structured as a Turkish joint stock company (Anonim Şirket) and employs between 501 and 1,000 people. Its core function is the manufacture and distribution of pharmaceutical products for the Turkish domestic market. Specific product names, therapeutic categories, dosage forms, and underlying manufacturing capabilities (e.g., API production, formulation, packaging) are not disclosed in available source material.

The company's primary identified customer segment is healthcare professionals — prescribers and administrators of pharmaceutical products — with the stated value proposition centered on adverse drug reaction monitoring and reporting. It operates a dedicated pharmacovigilance reporting channel branded "Pharmasoft," accessible via a dedicated phone line and email, and runs a Turkish-language website (adeka.com.tr) that gates product-area content behind a healthcare professional verification step. The company processes personal data of employees, business partners, and healthcare professionals under Turkey's KVKK (Kişisel Verilerin Korunması Kanunu, Law No. 6698), with documented provisions for cross-border data transfer.

The business model is consistent with a regulated domestic pharmaceutical manufacturer: revenue mechanics and pricing are not publicly disclosed, but Turkish pharmaceutical pricing is typically government-regulated and quote-based. There is no disclosed parent company, external investor, ownership structure, M&A activity, partnership, leadership team, patent portfolio, certification (e.g., GMP, ISO), or funding history. No applications, APIs, or third-party integrations are documented. Geographic reach is limited to Turkey, with no stated export franchise or international operations.

Name

ADEKA Pharmaceuticals

Legal name

Adeka İlaç Sanayi A.Ş.

Website

https://adeka.com.tr

Company type

Private

Founded year

1956

Operating status

Operating

Headcount range

501–1,000 employees

Short description

ADEKA Pharmaceuticals (Adeka İlaç Sanayi A.Ş.) is a Turkish pharmaceutical manufacturer founded in 1956 and headquartered in Istanbul. The company produces and distributes pharmaceutical products for the domestic market, serving healthcare professionals and operating a pharmacovigilance channel for adverse event reporting.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)

akta.pro secondary industry

Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI)

Keywords

• Pharmaceutical manufacturing
• Drug safety reporting
• Adverse event monitoring
• Pharmaceutical distribution
• Human medicines

Headquarters

HQ city

Maslak

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Core offering

ADEKA Pharmaceuticals manufactures and markets pharmaceutical products in Turkey. The company supports healthcare professionals with a drug safety reporting function, accepting adverse event reports by phone and dedicated email, and maintains a pharmacovigilance workflow for monitoring and recording product reactions.

Product overview

Adeka İlaç Sanayi A.Ş. (ADEKA Pharmaceuticals) is a pharmaceutical company based in Turkey that manufactures and distributes pharmaceutical products. The company operates in the healthcare sector, providing medicinal products and related services. Specific product names, modules, or product portfolio details are not available in the provided source material.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Direct peers

• Nobel İlaç: Established Turkish pharmaceutical manufacturer with a comparable mid-size portfolio of branded generics and specialty products distributed to physicians and pharmacists in Turkey.
• Santa Farma İlaç: Turkish pharmaceutical manufacturer with a similar mix of branded generics and specialty products distributed via medical representatives to Turkish prescribers.
• Abdi İbrahim: Turkey's largest domestic pharmaceutical manufacturer producing branded generics and specialty products for the same healthcare-professional customer base served by ADEKA from a Maslak, Istanbul-anchored operation.
• World Medicine İlaç: Turkish-headquartered pharmaceutical manufacturer with a parallel portfolio of generic and specialty products sold through healthcare professional channels in Turkey.
• Bilim İlaç: Turkish pharmaceutical company producing branded generics with a comparable field force and marketing model targeting Turkish physicians and pharmacists, overlapping with ADEKA's customer base.
• Ali Raif İlaç: Turkish pharmaceutical manufacturer founded in 1960s with similar mid-market positioning, supplying generic and branded products through healthcare professionals across Turkey.
• Eczacıbaşı Pharmaceuticals (EIP): Turkish pharma manufacturer marketing branded and OTC products through healthcare professional channels; competes directly with ADEKA in the domestic Turkish market across similar therapeutic categories.

Broad incumbents

• Bayer Türk: Multinational pharmaceutical company's Turkish affiliate operating across prescription and consumer health, overlapping ADEKA's healthcare-professional customer base in Turkey.
• GSK Türkiye: Multinational pharmaceutical company's Turkish affiliate serving physicians and pharmacists with a broader specialty and vaccine portfolio that competes for the same prescribing share targeted by ADEKA.
• Sandoz Türkiye: Multinational generic and biosimilar powerhouse with a Turkish affiliate competing in many of the same generic categories ADEKA markets; broader global portfolio but overlapping domestic presence.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks4 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/adekailac

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADEKA Pharmaceuticals